tinostamustine (EDO-S101) - Mundipharma, Purdue
FDA Grants Orphan Drug Designation for Tinostamustine in Malignant Glioma (Purdue Press Release) Nov 10, 2025 
Orphan drug • Glioma
https://www.purduepharma.com/news/2025/11/10/fda-grants-orphan-drug-designation-for-tinostamustine-in-malignant-glioma/
 
Nov 10, 2025